• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

STUDY FOR THE CELLULAR MECHANISMS OF INHIBITORY EFFECT OF THE TYPE I INTERFERON ON HEPATOCARCINOGENESIS AND CLINICAL APPLICATIONS

Research Project

Project/Area Number 10670502
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKeio University

Principal Investigator

SAITO hidetsugu  Keio University, Internal Medicine, Assistant Professor, 医学部, 講師 (80186949)

Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1999: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1998: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsinterferon / liver cancer cells / sensitivity to drugs / single nucleotide polymorphisms / promoter activity / signal transduction / interferon regulatory factor-1 / cell cycle / 肝細胞癌 / インターフェロンα / 発癌抑制 / ヒト肝癌細胞株 / cadherin / catenin
Research Abstract

The type I interferon (IFN) has been utilized in the treatment of chronic liver diseases caused by viral infection. We investigated the rate of occurrence of hepatocellular carcinoma (HCC) after the IFN-treatment for chronic hepatitis C, and the results suggested that IFN actively inhibited its occurrence rate. The precise mechanism of IFN-induced inhibition of hepatocarcinogenesis, however, has not been well understood. Therefore, we studied in vitro effect of IFN on the growth of HCC cell lines. IFN dose-dependently inhibited the growth of a group of cell lines, while there was another group of cells, in which IFN did not fully inhibit their proliferation. We then studied the difference of DNA and mRNA expression of interferon regulatory factors (IRF-1 and IRF-2), which is one of important signal transduction factors in IFN-induced transduction pathways, between the cell lines. The difference in the IRF-1 DNA rearrangement and the amount of IRF-1 mRNA were detected between two types of cell lines. We discovered the mutation in the intron 8 of the IRF-1 gene that causes DNA rearrangement when DNA was digested with BamHI. Genomic analysis of DNA from ten healthy volunteers revealed that this mutation seems to be a kind of single nucleotide polymorphisms (SNPs). We further investigated the difference in the IRF-1 promoter region that causes the difference in the IRF-1 mRNA amount. We discovered four SNPs in the upstream of the IRF-1 gene, which actually showed different promoter activities in luciferase reporter assay.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] S. Tada, H. Saito, et al: "IRF-1 gene abnormality and loss growth inhibitory effect of interfelon-α in human hepatoma cell lines"International Journal of Oncology. 13. 1207-1216 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y. Han, H. Saito, N. R. Thummala, et al: "Adenovirus-mediated gene therapy of liver diseases"Seminars in Liver Diseases. 19(1). 49-59 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Ishii, H. Ebinuma, H. Saito: "Interferon therapy and long-term therapeutic outcome in chronic hepatitis C"Asian Medical Journal. 42(5). 207-213 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Takahashi, H. Saito, et al: "Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis."Journal of Hepatology. 31. 315-322 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Ebinuma, H. Saito, et al: "Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells"International Journal of Oncology. 15. 991-999 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Wakabayahsi, H. Saito, et al: "Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells."Oncology Reports. 7. 285-288 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saito, et al.: "High serum level of P-selectin in patients responded to interferon-a treatment for chronic hepatits C."Hepatol. Res.. 10. 225-236 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saito, et al.: "Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression."Hepatology. 27(5). 1233-1240 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saito, et al.: "Short-course of interferon-β for the treatment of chronic hepatitis C: A multicenter trial for evaluating host immunological parameters"Int. J. Immunotherapy. 14(2). 115-128 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Shigematsu, et al.: "Endothelins promote egg albumin-induced intestinal anaphylaxis in rats"astroenterology. 115. 348-356 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Shigematsu, et al.: "Induction of endothelin-1 synthesis by IL-2 and its modulation of rat intestinal epithelial cell growth"Am J. Physiol.. 275. G556-G563 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T, Okuyama, et al.: "Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with El /E3-deleted adenoviral vectors."J. Gastroenterol. Hepatol.. 13. S113-118 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] S. Tada, H. Saito, et al.: "Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effcet of interferon-a in human hepatoma cell lines"Int. J. Oncol.. 13. 1207-1216 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] S. Miyaguchi, et al.: "Novel therapeutic approach to primary biliary cirrhosis patients: anti-eosinophil strategy"Hepatogadtroenterology. 45(23). 1457-1461 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y. Ilan, H. Saito, et al.: "Adenovirus-mediated gene therapy of liver diseases."Semin. Liver Dis.. 19(1). 49-59 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Ishii, H. Ebinuma, H. Saito, et al.: "Interferon therapy and long-term therapeutic outcome in chronic hepatitis C."Asian med. J.. 42(5). 207-213 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Takahashi, H. Saito, et al.: "Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis"J. Hepatol.. 31. 315-322 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Ebinuma, H. Saito, et al.: "Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells"nt. J. Oncol.. 15. 991-999 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Wakabayashi, H. Saito, et al.: "Bcl-2 related proteins are dramatically unduced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period."Oncol. Reports. 7. 285-288 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saito, et al.: "Results of the multicenter interferon-α2a treatment for chronic hepatitis C: Correlation between hepatitis C virus RNA negativity at two days and long-term virological response, and lymphocyte subpopulations and their modification caused by interferon"J. Viral Hepatitis. 7. 64-74 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Masuda, H. Saito, et al.: "Upregulatlon of E-cadherin and β-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-α."In Vitro Cell. Develop. Biol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y.Ilan,H.Saito,N.R.Thummala,N.R.Chowdhury: "Adenovirus-mediated gene therapy of liver diseases"Seminars in Liver Diseases. 19(1). 49-59 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] H.Ishii,Ebinuma,H.Saito chronic hepatitis C: "Interferon therapy and long-term therapeutic outcome in"Asian Medical Journal. 42(5). 207-213 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] M.Takahashi,H.Saito,et al.: "Overexpression of Bcl-2 protects human hepatoma cells from Fas antibody mediated apoptosis"Journal of Hepatology. 31. 315-322 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] H.Ebinuma,H.Saito,et al.: "Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells"International Journal of Oncology. 15. 991-999 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Wakabayashi,H.Saito,et al.: "Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells"Oncology Reports. 7. 285-288 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] T.Masuda,H.Saito,et al..: "Upregulation of E-cadherin and β-catenin in human hepatocellular carcinoma cell lines by sodium butyrate"In Vitro Cellular Development and Biology(Animal). (in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Saito H,et al.: "Loss of butyrate-induced apoptosis in human hepatoma cell lines HCG-M and HCC-T having substantial Bcl-2 expression" Hepatology. 27. 1233-1240 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tada S,Saito H,et al.: "Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-α in human hepatoma cell lines" International Journal of Oncology. 13. 1207-1216 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Takahashi M,Saito H,et al.: "Overexpression of Bcl-2 protects apoptosis of human hepatoma cells induced by anti-Fas antibody" Journal of Hepatology. (in press). (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi